Jui‐Yi Chen

1.2k total citations · 1 hit paper
62 papers, 604 citations indexed

About

Jui‐Yi Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Jui‐Yi Chen has authored 62 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Surgery and 20 papers in Nephrology. Recurrent topics in Jui‐Yi Chen's work include Diabetes Treatment and Management (13 papers), Chronic Kidney Disease and Diabetes (12 papers) and Acute Kidney Injury Research (12 papers). Jui‐Yi Chen is often cited by papers focused on Diabetes Treatment and Management (13 papers), Chronic Kidney Disease and Diabetes (12 papers) and Acute Kidney Injury Research (12 papers). Jui‐Yi Chen collaborates with scholars based in Taiwan, United States and Australia. Jui‐Yi Chen's co-authors include Vin‐Cent Wu, Heng‐Chih Pan, Min‐Hsiang Chuang, Hsien‐Yi Wang, Kuo‐Chuan Hung, Chiao‐Yin Sun, Sheng-Yin Chen, Shih‐Chieh Chueh, Hsing‐Yu Chen and Hung‐Wei Liao and has published in prestigious journals such as Nature Communications, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jui‐Yi Chen

48 papers receiving 598 citations

Hit Papers

From Acute to Chronic: Unraveling the Pathophysiological ... 2024 2026 2025 2024 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jui‐Yi Chen Taiwan 15 188 167 145 83 62 62 604
Alexia Piperidou Greece 7 272 1.4× 109 0.7× 112 0.8× 121 1.5× 173 2.8× 12 607
Christian W. Mende United States 12 183 1.0× 167 1.0× 80 0.6× 89 1.1× 85 1.4× 23 445
Lale A. Ertuğlu United States 15 153 0.8× 186 1.1× 164 1.1× 182 2.2× 165 2.7× 41 732
Winnie Huang United States 10 342 1.8× 175 1.0× 270 1.9× 180 2.2× 52 0.8× 13 751
Kimio Watanabe Japan 14 94 0.5× 254 1.5× 139 1.0× 58 0.7× 43 0.7× 41 586
Cinzia Lombardi Italy 16 146 0.8× 150 0.9× 69 0.5× 119 1.4× 132 2.1× 34 677
Jihun Kang South Korea 14 57 0.3× 142 0.9× 125 0.9× 162 2.0× 43 0.7× 66 755
Kazo Kaizu Japan 14 140 0.7× 183 1.1× 64 0.4× 66 0.8× 49 0.8× 39 573
Donghai Liu China 13 111 0.6× 112 0.7× 130 0.9× 203 2.4× 142 2.3× 35 709

Countries citing papers authored by Jui‐Yi Chen

Since Specialization
Citations

This map shows the geographic impact of Jui‐Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui‐Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui‐Yi Chen more than expected).

Fields of papers citing papers by Jui‐Yi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui‐Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui‐Yi Chen. The network helps show where Jui‐Yi Chen may publish in the future.

Co-authorship network of co-authors of Jui‐Yi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jui‐Yi Chen. A scholar is included among the top collaborators of Jui‐Yi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui‐Yi Chen. Jui‐Yi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chuang, Min‐Hsiang, et al.. (2025). Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study. BMJ Open. 15(2). e092752–e092752.
3.
Chuang, Min‐Hsiang, et al.. (2025). Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD. Nephrology Dialysis Transplantation. 40(10). 1897–1905. 1 indexed citations
4.
Huang, Chien‐Wei, et al.. (2025). Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 14(3). e038714–e038714. 3 indexed citations
5.
Chen, Jui‐Yi, et al.. (2024). Distinct phenotyping of critical patients with demand-capacity imbalance initiating acute renal replacement therapy by consensus clustering. Journal of the Formosan Medical Association. 124(11). 1018–1026.
6.
Chen, Jui‐Yi, et al.. (2024). The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients. Nature Communications. 15(1). 10043–10043. 14 indexed citations
7.
Chen, Jui‐Yi, Szu‐Yu Pan, Min‐Hsiang Chuang, et al.. (2024). Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs. Kidney Research and Clinical Practice. 43(4). 393–405. 1 indexed citations
9.
Wu, Ping‐Hsun, et al.. (2024). Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis. Therapeutic Advances in Chronic Disease. 15. 394288351–394288351. 7 indexed citations
11.
Chuang, Min‐Hsiang, Jui‐Yi Chen, Heng‐Chih Pan, et al.. (2024). Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal. 48(2). 242–252. 4 indexed citations
12.
Pan, Heng‐Chih, Jui‐Yi Chen, Hsing‐Yu Chen, et al.. (2024). Sodium-Glucose Cotransport Protein 2 Inhibitors in Patients With Type 2 Diabetes and Acute Kidney Disease. JAMA Network Open. 7(1). e2350050–e2350050. 36 indexed citations
13.
Chen, Jui‐Yi, et al.. (2024). Diagnostic efficacy of aldosterone-to-renin ratio to screen primary aldosteronism in hypertension: a systemic review and meta-analysis. Therapeutic Advances in Endocrinology and Metabolism. 15. 2455672709–2455672709.
14.
Pan, Heng‐Chih, Vin‐Cent Wu, Min‐Hsiang Chuang, et al.. (2023). Acute kidney injury in patients with COVID-19 compared to those with influenza: a systematic review and meta-analysis. Frontiers in Medicine. 10. 1252990–1252990. 5 indexed citations
16.
Hung, Kuo‐Chuan, Chin‐Wei Hsu, Jui‐Yi Chen, et al.. (2023). The efficacy and safety of cuttlebone for lowering serum phosphate in patients with end-stage renal disease: a meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 14. 1206366–1206366.
17.
Chen, Jui‐Yi, Kuo‐How Huang, Yen‐Hung Lin, et al.. (2023). Association of Dip in eGFR With Clinical Outcomes in Unilateral Primary Aldosteronism Patients After Adrenalectomy. The Journal of Clinical Endocrinology & Metabolism. 109(3). e965–e974. 4 indexed citations
18.
Chen, Jui‐Yi, et al.. (2022). Microfluidic Compartmentalization Platforms for Single Cell Analysis. Biosensors. 12(2). 58–58. 17 indexed citations
19.
Sun, Cheuk‐Kwan, Min‐Hsien Chiang, Jui‐Yi Chen, et al.. (2022). Effect of Intraoperative Phrenic Nerve Infiltration on Postoperative Ipsilateral Shoulder Pain After Thoracic Surgeries: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. Journal of Cardiothoracic and Vascular Anesthesia. 36(8). 3334–3343. 5 indexed citations
20.
Hung, Kuo‐Chuan, et al.. (2022). Impact of type of dialyzable beta-blockers on subsequent risk of mortality in patients receiving dialysis: A systematic review and meta-analysis. PLoS ONE. 17(12). e0279680–e0279680. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026